Analysis of the international epidemiological situation of bladder cancer

Abstract

Introduction: Bladder Cancer is one of the ten most frequent neoplasms in the world. It is classified as non-muscle invasive, muscle invasive, and metastatic. It has a high prevalence and recurrence rate, generating a high cost for the population. Objective: To describe the international incidence and mortality of Bladder Cancer during 2000-2019. Methodology: Descriptive observational study, based on epidemiological data from the Institute for Health Metrics and Evaluation, on Bladder Cancer between 2000-2019. Data on magnitude, mortality and disability-adjusted life years were collected. Results: During the period, incidence was maintained and mortality decreased by 11,7%. Men were three times more likely to develop bladder cancer and 2,8 times more likely to die in men than in women. People over 70 years of age have 34,7 times more risk of dying compared to younger people. High-income countries have higher incidence and mortality, although their lethality is lower in relation to low-income regions. Discussion: 80% of the diagnosis of Bladder Cancer is over 65 years of age. Incidence and mortality worldwide are higher in men, over 70 years of age and in high-income countries. Although the mortality of this cancer is decreasing, patients live with more years of disability, due to its high recurrence rate. Conclusion: Bladder Cancer varies according to sex, age and geography. Patients have more years of disability influencing a high economic cost and quality of life of people.